ArticleInternational journal of hematology2019
An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells.
Yu Mizutani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it